» Articles » PMID: 24454850

Topical Cream-based Dosage Forms of the Macrocyclic Drug Delivery Vehicle Cucurbit[6]uril

Overview
Journal PLoS One
Date 2014 Jan 24
PMID 24454850
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6]uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.

Citing Articles

Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.

Li S, Lin X, Xu K, He J, Yang H, Li H Sci Rep. 2017; 7:45984.

PMID: 28368030 PMC: 5377470. DOI: 10.1038/srep45984.


Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs.

Robinson E, Zavalij P, Isaacs L Supramol Chem. 2015; 27(5-6):288-297.

PMID: 25937787 PMC: 4412466. DOI: 10.1080/10610278.2014.940952.

References
1.
Walker S, Kaur R, McInnes F, Wheate N . Synthesis, processing and solid state excipient interactions of cucurbit[6]uril and its formulation into tablets for oral drug delivery. Mol Pharm. 2010; 7(6):2166-72. DOI: 10.1021/mp100191b. View

2.
Cheng X, Liang L, Chen K, Ji N, Xiao X, Zhang J . Twisted cucurbit[14]uril. Angew Chem Int Ed Engl. 2013; 52(28):7252-5. DOI: 10.1002/anie.201210267. View

3.
Wheate N . Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils. J Inorg Biochem. 2008; 102(12):2060-6. DOI: 10.1016/j.jinorgbio.2008.06.005. View

4.
Bhasikuttan A, Pal H, Mohanty J . Cucurbit[n]uril based supramolecular assemblies: tunable physico-chemical properties and their prospects. Chem Commun (Camb). 2011; 47(36):9959-71. DOI: 10.1039/c1cc12091c. View

5.
Lagona J, Mukhopadhyay P, Chakrabarti S, Isaacs L . The cucurbit[n]uril family. Angew Chem Int Ed Engl. 2005; 44(31):4844-70. DOI: 10.1002/anie.200460675. View